CRISPR THERAPEUTICS AG (CRSP)
CH0334081137 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 915M 130,614.29% | 1.2M -99.87% | 371.206M 30,833.83% | 16.001M -95.69% | 139.15M 769.63% | 691.58M 397.00% | 1.023B 47.92% | 1.549B 51.42% | 2.78B 79.47% | 5.299B 90.61% | 1.453B -72.58% | |
| EBITDA YoY % growth | 391.5M 213.41% | -649M -265.77% | -202.701M 68.77% | -478.463M -136.04% | -461.662M 3.51% | -398.022M 13.78% | -232.56M 41.57% | 33.66M 114.47% | 379.44M 1,027.27% | 728.28M 91.94% | 1.214B 66.69% | |
| EBIT YoY % growth | 373.5M 205.39% | -673.2M -280.24% | -222.538M 66.94% | -526.386M -136.54% | -510.673M 2.99% | -328.417M 35.69% | -83.86M 74.47% | 202.61M 341.61% | 210.54M 3.91% | 390.1M 85.29% | 546.91M 40.20% | |
| Operating Margin | 40.82% | -56,100.00% | -59.95% | -3,289.71% | -366.99% | -47.49% | -8.20% | 13.08% | 7.57% | 7.36% | 37.64% | |
| EPS YoY % growth | 4.42 183.87% | -8.37 -289.37% | -1.96 76.58% | -5.26 -168.27% | -5.12 2.60% | -3.18 37.90% | -0.57 81.94% | 2.73 575.67% | 9.47 246.53% | 22.71 139.95% | 6.10 -73.12% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.24 -212.71% | -1.38 3.78% | -1.36 8.71% | -1.25 -24.15% | -1.23 1.00% | -0.83 39.95% | -0.83 39.26% | -0.13 89.43% | 0.06 104.99% |
| Revenue Q2Q % growth | 8.142M -95.95% | 10.755M 2,033.93% | 15.708M 2,938.30% | 20.852M 3,363.79% | 27.593M 238.90% | N/A | N/A | N/A | N/A |
| EBITDA Q2Q % growth | -154.26M -272.51% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -122.487M -276.03% | -136.445M 2.95% | -136.944M 9.46% | -126.296M -14.68% | -130.443M -6.49% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -1.01 28.37% | -1.45 | 0.44 | 30.41% |
| Q2 2024 Q2Q % growth | -1.49 -52.04% | -1.55 | 0.06 | 4.06% |
| Q1 2024 Q2Q % growth | -1.43 -113.43% | -1.36 | -0.07 | -5.19% |
| Q4 2023 Q2Q % growth | 1.10 178.01% | -0.07 | 1.17 | 1,593.05% |
| Q3 2023 Q2Q % growth | -1.41 37.05% | -1.99 | 0.58 | 29.13% |
| Q2 2023 Q2Q % growth | -0.98 59.17% | -2.16 | 1.18 | 54.63% |
| Q1 2023 Q2Q % growth | -0.67 71.12% | -1.74 | 1.07 | 61.43% |
| Q4 2022 Q2Q % growth | -1.41 23.37% | -2.35 | 0.94 | 39.87% |
| Q3 2022 Q2Q % growth | -2.24 -34.13% | -2.34 | 0.10 | 4.11% |
| Q2 2022 Q2Q % growth | -2.40 -125.42% | -2.27 | -0.13 | -5.64% |
| Q1 2022 Q2Q % growth | -2.32 -53.64% | -1.98 | -0.34 | -17.46% |
| Q4 2021 Q2Q % growth | -1.84 -22.67% | -1.80 | -0.04 | -1.98% |
| Q3 2021 Q2Q % growth | -1.67 -26.52% | -1.79 | 0.12 | 6.77% |
| Q2 2021 Q2Q % growth | 9.44 826.15% | 3.59 | 5.85 | 162.72% |
| Q1 2021 Q2Q % growth | -1.51 -31.30% | -1.50 | -0.01 | -0.53% |
| Q4 2020 Q2Q % growth | -1.50 -394.12% | -1.30 | -0.20 | -15.52% |
| Q3 2020 Q2Q % growth | -1.32 -155.00% | -1.21 | -0.11 | -9.22% |
| Q2 2020 Q2Q % growth | -1.30 -28.71% | -0.97 | -0.33 | -34.71% |
| Q1 2020 Q2Q % growth | -1.15 -23.66% | -1.07 | -0.08 | -7.34% |
| Q4 2019 Q2Q % growth | 0.51 155.43% | -0.64 | 1.15 | 179.88% |
| Q3 2019 Q2Q % growth | 2.40 324.30% | -0.97 | 3.37 | 348.11% |
| Q2 2019 Q2Q % growth | -1.01 -23.17% | -0.92 | -0.09 | -10.27% |
| Q1 2019 Q2Q % growth | -0.93 -50.00% | -0.90 | -0.03 | -3.20% |
| Q4 2018 Q2Q % growth | -0.92 | -0.79 | -0.13 | -16.20% |
| Q3 2018 Q2Q % growth | -1.07 | -0.76 | -0.31 | -41.31% |
| Q2 2018 Q2Q % growth | -0.82 | -0.64 | -0.18 | -27.51% |
| Q1 2018 Q2Q % growth | -0.62 | -0.68 | 0.06 | 9.29% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 602K | 6.944M | -6.342M | -91.33% |
| Q2 2024 Q2Q % growth | 517K -99.26% | 3.609M | -3.092M | -85.67% |
| Q1 2024 Q2Q % growth | 504K -99.50% | 27.076M | -26.572M | -98.14% |
| Q4 2023 Q2Q % growth | 201.206M | 134.27M | 66.936M | 49.85% |
| Q3 2023 Q2Q % growth | -100.00% | 8.117M | -8.117M | -100.00% |
| Q2 2023 Q2Q % growth | 70M 34,900.00% | 1.742M | 68.258M | 3,918.37% |
| Q1 2023 Q2Q % growth | 100M 11,011.11% | 23.44M | 76.56M | 326.62% |
| Q4 2022 Q2Q % growth | -100.00% | 7.265M | -7.265M | -100.00% |
| Q3 2022 Q2Q % growth | 100K -87.50% | 1.649M | -1.549M | -93.94% |
| Q2 2022 Q2Q % growth | 200K -99.98% | 2.105M | -1.905M | -90.50% |
| Q1 2022 Q2Q % growth | 900K 80.00% | 2.82M | -1.92M | -68.09% |
| Q4 2021 Q2Q % growth | 12.9M 3,125.00% | 2.318M | 10.582M | 456.51% |
| Q3 2021 Q2Q % growth | 800K 700.00% | 1.145M | -345K | -30.13% |
| Q2 2021 Q2Q % growth | 900.7M | 429.34M | 471.36M | 109.79% |
| Q1 2021 Q2Q % growth | 500K 150.00% | 1.159M | -659K | -56.86% |
| Q4 2020 Q2Q % growth | 400K -99.48% | 2.372M | -1.972M | -83.14% |
| Q3 2020 Q2Q % growth | 100K -99.95% | 2.066M | -1.966M | -95.16% |
| Q2 2020 Q2Q % growth | -100.00% | 18.488M | -18.488M | -100.00% |
| Q1 2020 Q2Q % growth | 200K -33.33% | 3.103M | -2.903M | -93.55% |
| Q4 2019 Q2Q % growth | 77M 76,900.00% | 36.543M | 40.457M | 110.71% |
| Q3 2019 Q2Q % growth | 211.9M 35,216.67% | 6.279M | 205.621M | 3,274.74% |
| Q2 2019 Q2Q % growth | 300K -72.73% | 4.016M | -3.716M | -92.53% |
| Q1 2019 Q2Q % growth | 300K -78.57% | 1.785M | -1.485M | -83.19% |
| Q4 2018 Q2Q % growth | 100K | 2.697M | -2.597M | -96.29% |
| Q3 2018 Q2Q % growth | 600K | 2.696M | -2.096M | -77.74% |
| Q2 2018 Q2Q % growth | 1.1M | 1.862M | -762K | -40.92% |
| Q1 2018 Q2Q % growth | 1.4M | 2.561M | -1.161M | -45.33% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 6.33% | 0% | 10.45% |
| Revenue | -4.26% | -81.39% | -36.38% | -68.46% |